Table 3.
GA 2 | FO | PU | EAD | ET-I | ET-II | ET-III | ET- IV | FG | ET-V | ET- VI |
ET- VII |
ET- VIII |
EA | ET- IX |
AG | LG-I | LG- II |
ABTS | DPPH | FRAP | TPs | OPs | TFs | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FO | 0.62 | |||||||||||||||||||||||
PU | −0.06 | −0.68 | ||||||||||||||||||||||
EAD | −0.48 | 0.23 | −0.81 | |||||||||||||||||||||
ET-I | 0.50 | −0.14 | 0.60 | −0.84 * | ||||||||||||||||||||
ET-II | 0.30 | −0.44 | 0.76 | −0.82 * | 0.94 **,1 | |||||||||||||||||||
ET-III | −0.58 | 0.20 | −0.69 | 0.89 * | −0.95** | −0.95 ** | ||||||||||||||||||
ET-IV | −0.21 | 0.54 | −0.93 ** | 0.85 * | −0.58 | −0.74 | 0.76 | |||||||||||||||||
FG | 0.51 | −0.26 | 0.73 | −0.90 * | 0.96 ** | 0.97 ** | −0.99 *** | −0.77 | ||||||||||||||||
ET-V | 0.55 | −0.17 | 0.63 | −0.85 * | 0.98 *** | 0.96 ** | −0.99 *** | −0.66 | 0.99 *** | |||||||||||||||
ET-VI | −0.55 | 0.24 | −0.72 | 0.91 * | −0.94 ** | −0.95 ** | 0.99 *** | 0.79 | −0.99 *** | −0.98 *** | ||||||||||||||
ET-VII | −0.22 | 0.49 | −0.80 | 0.73 | −0.37 | −0.54 | 0.61 | 0.95 ** | −0.60 | −0.47 | 0.64 | |||||||||||||
ET-VIII | −0.40 | 0.40 | −0.87 * | 0.93 ** | −0.69 | −0.79 | 0.85 * | 0.97 ** | −0.85 * | −0.76 | 0.87 * | 0.92 ** | ||||||||||||
EA | 0.60 | 0.04 | 0.40 | −0.77 | 0.95 ** | 0.82 * | −0.86 * | −0.41 | 0.87 * | 0.91 * | −0.85 * | −0.22 | −0.57 | |||||||||||
ET-IX | 0.78 | 0.15 | 0.47 | −0.86 * | 0.92 ** | 0.79 | −0.93 ** | −0.57 | 0.91 * | 0.93 ** | −0.92 * | −0.43 | −0.72 | 0.93 ** | ||||||||||
AG | 0.06 | −0.50 | 0.75 | −0.73 | 0.89 * | 0.93 ** | −0.80 | −0.59 | 0.85 * | 0.85 * | −0.81 | −0.34 | −0.62 | 0.78 | 0.66 | |||||||||
LG-I | 0.03 | −0.53 | 0.75 | −0.72 | 0.88 * | 0.93 ** | −0.79 | −0.60 | 0.84 * | 0.84 * | −0.80 | −0.35 | −0.62 | 0.76 | 0.64 | 0.99 *** | ||||||||
LG-II | 0.06 | −0.42 | 0.69 | −0.72 | 0.88 * | 0.88 * | −0.75 | −0.51 | 0.81 | 0.82 * | −0.76 | −0.25 | −0.56 | 0.80 | 0.66 | 0.99 *** | 0.98 *** | |||||||
ABTS | −0.08 | 0.66 | −0.95 ** | 0.84 * | −0.77 | −0.92 * | 0.84 * | 0.91 * | −0.87 * | −0.81 | 0.86 * | 0.76 | 0.88 * | −0.58 | −0.62 | −0.86 * | −0.87 * | −0.79 | ||||||
DPPH | 0.02 | 0.72 | −0.90 * | 0.75 | −0.44 | −0.64 | 0.60 | 0.95 ** | −0.63 | −0.50 | 0.64 | 0.94 ** | 0.89 * | −0.28 | −0.37 | −0.54 | −0.55 | −0.46 | 0.86 * | |||||
FRAP | −0.26 | 0.52 | −0.83 * | 0.91 * | −0.75 | −0.84 * | 0.82 * | 0.88 * | −0.85 * | −0.78 | 0.85 * | 0.80 | 0.92 ** | −0.68 | −0.69 | −0.74 | −0.74 | −0.71 | 0.89 * | 0.88 * | ||||
TPs | 0.03 | 0.35 | −0.82 | 0.79 | −0.61 | −0.59 | 0.54 | 0.63 | −0.60 | −0.54 | 0.57 | 0.45 | 0.64 | −0.51 | −0.51 | −0.72 | −0.72 | −0.77 | 0.71 | 0.60 | 0.66 | |||
OPs | 0.21 | 0.70 | −0.77 | 0.38 | −0.19 | −0.46 | 0.39 | 0.78 | −0.40 | −0.29 | 0.42 | 0.75 | 0.63 | 0.10 | −0.07 | −0.36 | −0.37 | −0.23 | 0.72 | 0.76 | 0.46 | 0.33 | ||
TFs | −0.25 | 0.56 | −0.91 * | 0.90 * | −0.78 | −0.91 * | 0.89 * | 0.95 ** | −0.91 * | −0.83 * | 0.91 * | 0.84 * | 0.96 ** | −0.62 | −0.70 | −0.79 | −0.79 | −0.71 | 0.98 *** | 0.89 * | 0.94 ** | 0.65 | 0.68 | |
CTs | −0.01 | 0.70 | −0.94 ** | 0.79 | −0.76 | −0.92 * | 0.81 * | 0.87 * | −0.85 * | −0.79 | 0.84 * | 0.70 | 0.84 * | −0.56 | −0.57 | −0.89 * | −0.89 * | −0.82 | 0.99 *** | 0.83 * | 0.86 * | 0.70 | 0.72 | 0.95 ** |
1 Values in bold represent the * significant at p < 0.05; ** significant at p < 0.01; and *** significant at p < 0.001. 2 Abbreviations: GA, gallic acid; FO, flavan-3-ols; PU, punicalins; EAD, ellagic acid derivative; ET-I, ellagitannin I; ET-II, ellagitannin II; ET-III, ellagitannin III; ET-IV, ellagitannin IV; FG, flavonol glycoside; ET-V, ellagitannin V; ET-VI, ellagitannin VI; ET-VII, ellagitannin VII; ET-VIII, ellagitannin VIII; EA, ellagic acid; ET-IX, ellagitannin IX; AG, apigenin glycoside; LG-I, luteolin glycoside I; LG-II, luteolin glycoside II; TPs, total phenols; OPs, ortho-diphenols; TFs, total flavonoids, and CTs, condensed tannins.